Gemmill, Marin

Number of items: 7.
None
  • Costa-Font, Joan, Gemmill, Marin, Rubert, Gloria (2011). Biases in the healthcare luxury good hypothesis?: a meta-regression analysis. Journal of the Royal Statistical Society. Series A: Statistics in Society, 174(1), 95-107. https://doi.org/10.1111/j.1467-985X.2010.00653.x
  • Mossialos, Elias, Morel, Chantal M., Edwards, S. E., Berensen, J., Gemmill, Marin, Brogen, D. (2010). Policies and incentives for promoting innovation in antibiotic research. European Observatory on Health Systems and Policies.
  • Gemmill, Marin, Costa-i-Font, Joan, McGuire, Alistair (2007). In search of a corrected prescription drug elasticity estimate: a meta-regression approach. Health Economics, 16(6), 627-643. https://doi.org/10.1002/hec.1190
  • Gemmill, Marin, Costa-i-Font, Joan, Kanavos, Panos (2006). Insurance coverage and the heterogeneity of health and drug spending in the United States. Geneva Papers on Risk and Insurance: Issues and Practice, 31(4), 669-691. https://doi.org/10.1057/palgrave.gpp.2510098
  • Kanavos, Panos, Gemmill, Marin (2005). Pharmaceutical pricing and reimbursement in Europe. Scrip (Firm).
    • Public
  • Costa-i-Font, Joan, Gemmill, Marin, Rubert, Gloria (2009). Re-visiting the health care luxury good hypothesis: aggregation, precision, and publication biases? (HEDG working papers 09/02). Health, Econometrics and Data Group (HEDG).
  • Gemmil, Marin (2008). The price elasticity of demand for prescription drugs An exploration of demand in different settings. [Doctoral thesis]. London School of Economics and Political Science.